Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease

American Journal of Ophthalmology

Volumn 154, Issue 1, 2012, Pages 72-77

  Abbasian, Javaneh ^a   Martin, Tammy M ^b   Patel, Sarju ^a   Tessler, Howard H ^a   Goldstein, Debra A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; FUNGUS ANTIBODY; GENOMIC DNA; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FAMILY HISTORY; FEMALE; GENETIC MARKER; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; UVEITIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENETIC MARKERS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RETROSPECTIVE STUDIES; UVEITIS; YOUNG ADULT;

EID: 84862771313     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.01.016     Document Type: Article

References (31)

1. Chan SM, Hudson M, Weis E. Anterior and intermediate uveitis cases referred to a tertiary centre in Alberta. Can J Ophthalmol 2007;42(6):860-864.
2. Mintz R, Feller E, Bahr R, Shah SA. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2004;10(2):135-139. (Pubitemid 38332174)
3. Turkcapar N, Toruner M, Soykan I, et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int 2006;26(7):663- 668.
4. Taylor SR, McCluskey P, Lightman S. The ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol 2006;17(6):538-544. (Pubitemid 44655587)
5. Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997;115(1):61-64. (Pubitemid 27034932)
6. Lin P, Tessler HH, Goldstein DA. Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation. Am J Ophthalmol 2006;141(6):1097-1104. (Pubitemid 43831059)
7. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411(6837):599-603. (Pubitemid 32531408)
8. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411(6837):603- 606. (Pubitemid 32531409)
9. Shanahan F, Duerr RH, Rotter JI, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992;103:456-461.
10. Sendid B, Quinton J, Charrier G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998;93:1306-1310. (Pubitemid 29076932)
11. Seibold F, Slametschka D, Gregor M, et al. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994;107:532-536. (Pubitemid 24233330)
12. Vermeire S, Peeters M, Vlietinck R, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001;7(1):8-15.
13. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70(4):845- 857.
14. Torres MI, Rios A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J Gastroenterol 2008;14(13):1972-1980. (Pubitemid 351795814)
15. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361(21):2066-2078.
16. Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011; 106(1):110-119.
17. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55(5):401-412.
18. Bañares AA, Jover JA, Fernandez-Gutierrez B, et al. Bowel inflammation in anterior uveitis and spondyloarthropathy. J Rheumatol 1995;22(6):1112-1117.
19. Mielants H, Veys EM, Joos R, Suykens S, Cuvelier C, De Vos M. Familial aggregation in seronegative spondyloarthritis of enterogenic origin. A family study. J Rheumatol 1986;13(1):126-128. (Pubitemid 16118738)
20. Mielands H, Veys EM, Verbraken H, De Vos M, Cuvelier C. HLA-B27 positive idiopathic acute anterior uveitis: a unique manifestation of subclinical gut inflammation. J Rheumatol 1990;17(6):841- 842.
21. Mielants H, Veys EM, Curvelier C, De Vos M. Ileocolonoscopic findings in seronegative spondyloarthropathies. Br J Rheumatol 1988;27:S95-105.
22. Mielants H, Veys EM, Cuvelier C, De Vos M. Subclinical involvement of the gut in undifferentiated spondyloarthropathies. Clin Exp Rheumatol 1989;7(5):499-504. (Pubitemid 20069360)
23. Seibold F. ASCA: genetic marker, predictor of disease, or marker of a response to an environmental antigen? Gut 2005;54(9):1212-1213. (Pubitemid 41192475)
24. Faustini F, Zoli A, Ferraccioli GF. Immunologic and genetic links between spondyloarthropathies and inflammatory bowel diseases. Eur Rev Med Pharmacol Sci 2009;13(Suppl 1):1-9.
25. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000;47(4):487-496.
26. Rosenstiel P, Sina C, Franke A, Schreiber S. Towards a molecular risk map-recent advances on the etiology of inflammatory bowel disease. Semin Immunol 2009;21(6):334-345.
27. Mathew CG, Lewis CM. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 2004; 13(Spec No 1):R161-168. (Pubitemid 38443810)
28. Israeli E, Grotto I, Gilburd B, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005;54(9):1232-1236. (Pubitemid 41192480)
29. Yazdanyar S, Weischer M, Nordestgaard BG. Genotyping for NOD2 genetic variants and crohn disease: a metaanalysis. Clin Chem 2009;55(11):1950-1957.
30. Noomen CG, Hommes DW, Fidder HH. Update on genetics in inflammatory disease. Best Pract Res Clin Gastroenterol 2009;23(2):233-243.
31. Cooney R, Jewell D. The genetic basis of inflammatory bowel disease. Dig Dis 2009;27(4):428-442.